Skip to content
Clinical Trials – home

ALL-MED Specialistyczna Opieka Medyczna. Medyczny Instytut Badawczy

Verified siteinfo

Poland Al. Gen. Józefa Hallera 95, 53-201 Wroclaw, Poland

  • 2 trials recruiting
  • Conjunctivitis allergic · Asthmatic crisis · Chronic spontaneous urticaria
  • Adults and children

About Specializations

ALL-MED Specialistyczna Opieka Medyczna. Medyczny Instytut Badawczy in Wroclaw, Poland specialises in clinical trials of conditions such as Conjunctivitis allergic, Asthmatic crisis, Chronic spontaneous urticaria, Rhinitis allergic, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases

The ALL-MED Specialistyczna Opieka Medyczna. Medyczny Instytut Badawczy is conducting studies that target disorders of the immune system, focusing on severe asthma phenotypes and chronic urticaria.

  • Chronic Spontaneous Urticaria
  • Severe Asthma
  • Severe asthma with an eosinophilic phenotype

Trials aim to evaluate the safety and efficacy of emerging biologic therapies, offering potential new treatment options for patients whose conditions are difficult to control with standard care.

Otorhinolaryngologic Diseases

Research at the site emphasizes allergic diseases of the nose and eyes, investigating innovative approaches to reduce symptoms caused by seasonal and perennial allergens.

  • Birch Pollen-induced Allergic Rhinoconjunctivitis
  • Birch pollen induced allergic rhinitis or rhinoconjunctivitis
  • Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis with or without Asthma induced by House Dust Mite (HDM) Allergy
  • Perennial Allergic Rhinitis (PAR)
  • Seasonal allergic rhinitis/rhinoconjunctivitis induced by grass pollen exposure
  • Seasonal allergic rhinitis and/or rhinoconjunctivitis

The goal is to assess the clinical benefit of subcutaneous allergen immunotherapy and related treatments, improving quality of life for individuals suffering from chronic nasal and ocular allergy.

Respiratory Tract Diseases

The institute’s respiratory program concentrates on severe asthma, especially forms linked to eosinophilic inflammation, seeking to broaden therapeutic options.

  • Severe Asthma
  • Severe asthma with an eosinophilic phenotype

Ongoing studies evaluate novel anti‑IL-5 and anti‑IL-4 agents for their ability to reduce exacerbations and improve lung function in patients with uncontrolled disease.

Skin and Connective Tissue Diseases

Investigations into dermatologic immune conditions focus on chronic urticaria, a condition marked by recurrent hives and itching.

  • Chronic Spontaneous Urticaria

The research assesses the effectiveness of new monoclonal antibody treatments compared with placebo, targeting symptom relief and disease control.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Al. Gen. Józefa Hallera 9553-201 WroclawPoland
Recruiting now
2 trials
Conditions studied
4
Partner status
Verified site

More sites in WroclawPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Desloratadine
  • Sponsor:Allergy Therapeutics (UK) Limited

A study to evaluate the efficacy and safety of lesigercept in adults with chronic spontaneous urticaria who do not have enough relief from antihistamines

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Yuhan Corp.

Conjunctivitis allergic

Not yet recruiting

Study on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Allergy Therapeutics (UK) Limited

Asthmatic crisis

Not recruiting

Long-term safety and effectiveness study of verekitug injections in adults with severe asthma who completed the VALIANT trial

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Human IgG1 kappa monoclonal antibody against CRLF2
  • Sponsor:Upstream Bio Inc.

Conjunctivitis allergic+1

Not recruiting

Study on Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Betula Pendula Pollen Allergoid, Mannan-Conjugated, Polymerised
  • Sponsor:CCDRD Cooperative Clinical Drug Research and Development AG

Asthmatic crisis

Not recruiting

Study on the Effects of Verekitug (UPB-101) for Adults with Severe Asthma

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Human IgG1 kappa monoclonal antibody against CRLF2
  • Sponsor:Upstream Bio Inc.

Study on the Safety and Effectiveness of Betula Pollen Extract for Children and Adolescents Aged 5-17 with Birch Pollen Allergies and Possible Asthma

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Betula Pollen Extract
  • Sponsor:Stallergenes
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.